The $23 Billion Bet

How Novartis Is Building the Future of U.S. Healthcare

Pharma giant Novartis just announced a major move: it plans to invest $23 billion into its U.S. operations over the next five years. The focus? Expanding manufacturing capacity and strengthening research and development (R&D) across key regions. This isn’t just a win for the company—it’s a strategic decision that speaks volumes about the direction of he…